RNA vs affine

affine (SN120) is 8.6× the size of RNA (SN117) by market capitalisation. Over the past 30 days, SN117 is ahead by 41.1 percentage points (SN117 +21.4% against SN120 -19.7%). Their daily returns move closely together (correlation 0.80 across 25 shared trading days). SN117 has been the more volatile of the two, at 161% annualised against SN120's 118%.

Correlation: 0.80
Size ratio: 1 : 8.6
Ahead over 30 days: SN117

RNASN117

$1.7900

24h: -0.56%
Market cap: $5.12M
Volume 24h: $865,917
Volatility (ann.): 161%

affineSN120

$9.9500

24h: +3.79%
Market cap: $44.24M
Volume 24h: $158,626
Volatility (ann.): 118%

SN117 10.4%Share of the two combined market caps89.6% SN120

Performance

SN117SN120

7 days-18.52%-13.26%SN120
30 days+21.37%-19.70%SN117

Correlation

0.80over 25 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: 0.8090d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	SN117	SN120
Max drawdown (400d)	-28.8%	-37.7%
Risk-adjusted return (90d)	0.13	-0.16

Relative strength over 90 days: SN117 outperformed SN120 by 2.4% — measured on the SN117/SN120 ratio, so it holds regardless of market direction.

RNA →affine →